2011
DOI: 10.3201/eid1701.100244
|View full text |Cite
|
Sign up to set email alerts
|

Class D OXA-48 Carbapenemase in Multidrug-Resistant Enterobacteria, Senegal

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
20
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 77 publications
(20 citation statements)
references
References 9 publications
0
20
0
Order By: Relevance
“…For example, ESBL producers accounted for 5.2% of community‐acquired urinary tract infections caused by Escherichia coli in Senegal [23], 19.3% of Enterobacteriaceae in the Central African Republic [24], 32.9% of Enterobacteriaceae in Tanzania [25], 26.9% of Enterobacteriaceae in India [26] and 36.6% of E. coli in Cambodia [27]. In addition, as carbapenems are often the most effective antibiotics used against 3GC‐R Enterobacteriaceae , the emergence of carbapenem resistance, a phenomenon that has been described in Africa [28], but that was not found in our study, could become a serious challenge for infection control and antibiotic therapy in the future.…”
Section: Resultsmentioning
confidence: 99%
“…For example, ESBL producers accounted for 5.2% of community‐acquired urinary tract infections caused by Escherichia coli in Senegal [23], 19.3% of Enterobacteriaceae in the Central African Republic [24], 32.9% of Enterobacteriaceae in Tanzania [25], 26.9% of Enterobacteriaceae in India [26] and 36.6% of E. coli in Cambodia [27]. In addition, as carbapenems are often the most effective antibiotics used against 3GC‐R Enterobacteriaceae , the emergence of carbapenem resistance, a phenomenon that has been described in Africa [28], but that was not found in our study, could become a serious challenge for infection control and antibiotic therapy in the future.…”
Section: Resultsmentioning
confidence: 99%
“…). In Africa, they have been mainly identified in the northern countries (Morocco, Algeria, Tunisia, Egypt, and Libya) , but OXA‐48 producers have also been identified in Senegal and South Africa (Fig. ).…”
Section: The Carbapenem‐hydrolysing Class D β‐Lactamases (Chdls)mentioning
confidence: 99%
“…Considering carbapenemase production among E. coli isolates in the African continent, although many descriptions have been reported in humans (Robin et al 2010;Moquet et al 2011;Barguigua et al 2013;Leski et al 2013;Mushi et al 2014) and the hospital environment (Chouchani et al 2011) over the last 5 years, it has not been until very recently when the first carbapenemaseproducing E. coli was detected in pets (Yousfi et al 2016) and livestock animals (Braun et al 2016). The previously described study, conducted in different dairy cattle farms from Egypt, reported four E. coli strains harbouring bla OXA-48 and one carrying bla OXA-181 carbapenemase genes, all of them phenotypically resistant to meropenem and imipenem.…”
Section: Esbl Plasmid-mediated Ampc and Carbapenemase-producing E Cmentioning
confidence: 99%